Diabetes, Vol 42, Issue 6 883-890, Copyright © 1993 by American Diabetes Association

ARTICLES

A microtiter well assay system to measure insulin activation of insulin receptor kinase in intact human mononuclear cells. Decreased insulin effect in cells from patients with NIDDM

HH Klein, B Kowalewski, M Drenckhan, S Neugebauer, S Matthaei and G Kotzke
Department of Internal Medicine, Medical University of Lubeck, Germany.

A sensitive microtiter well-based assay for the measurement of insulin activation of insulin receptor kinase in intact human circulating mononuclear cells has been developed and characterized. Mononuclear cells from 100-150 ml blood were incubated with various insulin concentrations to activate the receptor kinase. The cells were then solubilized in the presence of phosphatase and kinase inhibitors and the receptors immobilized to microwells coated with anti-insulin receptor antibody (efficiency of receptor immobilization > 85%). Receptor kinase activity and binding activity were then consecutively measured in the same wells. Insulin incubation of the cells increased the kinase activity three- to fourfold with a half-maximal effect at 5 nM and a maximal effect at 87 nM. In mononuclear cells from 16 subjects with NIDDM, the insulin effect on receptor kinase activation was significantly reduced compared with 16 nondiabetic control subjects (0.135 +/- 0.016 vs. 0.195 +/- 0.024 fmol P.fmol binding activity-1 x min-1, respectively; P < 0.05). We conclude that; 1) it is possible to determine insulin activation of receptor kinase in intact cells in this easily accessible human tissue; 2) insulin activation of insulin receptor kinase is impaired in intact mononuclear cells from patients with NIDDM; and 3) the finding that kinase activation in NIDDM is reduced in a tissue that, according to the literature, contains only the A isoform of the insulin receptor, suggests that mechanisms other than a different abundance of the A and B insulin receptor isoforms must exist that contribute to the decreased kinase activity in NIDDM.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Meier, H. H Klein, J. Kramer, M. Drenckhan, and M. Schutt Calpain inhibition impairs glycogen syntheses in HepG2 hepatoma cells without altering insulin signaling J. Endocrinol., April 1, 2007; 193(1): 45 - 51. [Abstract] [Full Text] [PDF]

				D. B. Ring, K. W. Johnson, E. J. Henriksen, J. M. Nuss, D. Goff, T. R. Kinnick, S. T. Ma, J. W. Reeder, I. Samuels, T. Slabiak, et al. Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In Vivo Diabetes, March 1, 2003; 52(3): 588 - 595. [Abstract] [Full Text] [PDF]

				M. M. Meyer, K. Levin, T. Grimmsmann, N. Perwitz, A. Eirich, H. Beck-Nielsen, and H. H. Klein Troglitazone Treatment Increases Protein Kinase B Phosphorylation in Skeletal Muscle of Normoglycemic Subjects at Risk for the Development of Type 2 Diabetes Diabetes, September 1, 2002; 51(9): 2691 - 2697. [Abstract] [Full Text] [PDF]

				P. Jost, M. Fasshauer, C. R. Kahn, M. Benito, M. Meyer, V. Ott, B. B. Lowell, H. H. Klein, and J. Klein Atypical beta -adrenergic effects on insulin signaling and action in beta 3-adrenoceptor-deficient brown adipocytes Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E146 - E153. [Abstract] [Full Text] [PDF]

				Y. Ikeda, G. S. Olsen, E. Ziv, L. L. Hansen, A. K. Busch, B. F. Hansen, E. Shafrir, and L. Mosthaf-Seedorf Cellular Mechanism of Nutritionally Induced Insulin Resistance in Psammomys Obesus: Overexpression of Protein Kinase C{varepsilon} in Skeletal Muscle Precedes the Onset of Hyperinsulinemia and Hyperglycemia Diabetes, March 1, 2001; 50(3): 584 - 592. [Abstract] [Full Text]

				W. Derave, B. F. Hansen, S. Lund, S. Kristiansen, and E. A. Richter Muscle glycogen content affects insulin-stimulated glucose transport and protein kinase B activity Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E947 - E955. [Abstract] [Full Text] [PDF]

				A. G. Danielsen, F. Liu, Y. Hosomi, K. Shii, and R. A. Roth Activation of Protein Kinase Calpha Inhibits Signaling by Members of the Insulin Receptor Family J. Biol. Chem., September 15, 1995; 270(37): 21600 - 21605. [Abstract] [Full Text] [PDF]

				P.-Y. Chang, L. J. Goodyear, H. Benecke, J. S. Markuns, and D. E. Moller Impaired Insulin Signaling in Skeletal Muscles from Transgenic Mice Expressing Kinase-deficient Insulin Receptors J. Biol. Chem., May 26, 1995; 270(21): 12593 - 12600. [Abstract] [Full Text] [PDF]